# MiNK Therapeutics

Type: Company (INKT)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/mink-therapeutics
Canonical HTML page: https://gethealthbrief.com/entity/mink-therapeutics

## Timeline

- **2026-03-17**: Earnings Release — Expected date for Q4 and full-year 2025 financial results and clinical updates.
- **2026-03-15**: Earnings Preview — Market analysts highlight Tuesday as a key reporting date for both COYA and INKT.
- **2026-03-10**: MiNK Collaboration — MiNK Therapeutics announces partnership with C-Further for pediatric cancer therapies, stock rises 60%.

## Recent coverage (1 stories)

### Biotech Earnings Preview: Coya and MiNK Therapeutics Set for Tuesday Reports
2026-03-15 06:55:54 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Coya Therapeutics and MiNK Therapeutics are scheduled to release quarterly financial results this Tuesday, providing critical updates on their clinical pipelines and cash runways. Investors are closely monitoring MiNK's recent pediatric cancer collaboration and Coya's progress in neurodegenerative Treg therapies.
Full story: https://gethealthbrief.com/story/coya-mink-therapeutics-earnings-preview-march-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.